17/6 2024

Darren Stephens joins Radiobotics as Senior VP and Commercial Lead in UK/I and EU

Radiobotics, a pioneering leader in AI-driven radiology solutions, is pleased to announce the appointment of Darren Stephens as the new Senior Vice President and Commercial Lead for the UKI, EU, and Strategic Partnerships. Darren joins Radiobotics from Qure.ai, where he made significant contributions to the growth and success of the company’s AI-powered healthcare solutions.

Darren brings with him a wealth of experience in the medical technology, managed services and AI sectors. His track record is distinguished by successful market expansions, strategic partnerships, and driving substantial growth, for companies such as Ecolab, Roche Diagnostics, Everlight Radiology and most recently Qure.

At Radiobotics, Darren will be responsible for spearheading the company’s commercial strategies and operations across the UK and European markets, as well as strengthening relationships with strategic partners.

Peter Ulvskjold, CEO of Radiobotics, happily announced the news this morning, stating:

”We are thrilled to welcome Darren to the Radiobotics team. His expertise in commercial leadership and his deep understanding of AI in healthcare will be invaluable as we continue to expand our presence in the UKI, Europe, and beyond.
Darren’s vision aligns perfectly with our mission to revolutionize radiology with advanced AI solutions.

He expressed his enthusiasm about joining Radiobotics:
“I am excited to be part of a company that is at the forefront of AI innovation in radiology. Radiobotics has a remarkable portfolio of solutions that significantly improve diagnostic accuracy and efficiency. I look forward to working with the talented team at Radiobotics to drive growth and deliver cutting-edge solutions to our clients and partners”.
Radiobotics is dedicated to developing state-of-the-art AI tools designed to assist radiologists and improve patient outcomes. With Darren’s leadership, the company aims to enhance its commercial reach and establish a stronger foothold in key markets across UKI and Europe.

About MDR: